When corporate insiders sell stock at a loss, watch out

When considering whether to buy stock in a company, investors often look to the trading activity of the company's top executives. If the CEO or CFO has recently made large purchases of company stock, investors tend to assume ...

Study uncovers new hurdle for developing immunotherapies

The body's immune system is a valiant weapon against disease, and harnessing its power through a technique called immunotherapy is at the forefront of current research to treat cancer and other diseases.

page 18 from 40